Press Release – Joint Council for Cosmetic Practitioners (JCCP) And Committee of Advertising Issue New Enforcement Notice on the Advertisement of Prescription Only Medicines in Aesthetics
The Joint Council for Cosmetic Practitioners (JCCP) has been working closely with the Committee of Advertising Practice (CAP) and the Advertising Standards Authority (ASA) to strengthen and reinforce advertising standards and codes within the aesthetic sector.
The JCCP is aware of the many concerns that have been presented regarding a number of misleading and exaggerated claims and misleading strategies that have been used to advertise cosmetic treatments to members of the public and to practitioners, including the explicit promotion of Prescription Only Medicines (POMs) such as Botulinum Toxin. As a result we have continued our work with CAP and ASA to clarify the permissible and prohibited practices in discussion POMs with the general public.
Read the full article here with some helpful guidance on advertising:-